BOSWELLIA / INGREDIENT RESEARCH

Painful knees with osteoarthritis

Potential benefit studied: Possible reduction in knee pain

Positive human evidence

Small human trials · Reviewed 9 September 2026

WHAT THE RESEARCH FOUND

Several human trials found that boswellia extracts reduced knee pain compared with placebo.

WHO, WHAT & HOW LONG

A 90-day trial randomized 75 people to 5-Loxin, a boswellia extract containing 30% AKBA, at 100 or 250 mg daily, or placebo.

WHAT THIS MEANS FOR ROB’S CHOICE

Mobility's listed 100 mg Boswellia at 30% AKBA resembles one trial's stated amount and marker percentage. That does not establish equivalence to 5-Loxin or demonstrate the effectiveness of the Boswellia and moringa combination.

The doses above describe research, not personal dosing instructions. Ingredient studies do not diagnose symptoms or establish medical suitability. Discuss medicines, existing conditions and treatment decisions with an appropriate healthcare professional.